Market Place
Sourcing Support
atai Life Sciences Announces First Subject Dosed in Phase 1 Trial
05 Oct 2022 //
GLOBENEWSWIRE
Core One Labs` Scientists Successfully Complete Breakthrough in Producing API
02 Sep 2022 //
ACCESSWIRE
Cybin completes purchase of anxiety disorder treatment study
12 Jul 2022 //
CLINICALTRIALSARENA
Small Pharma Reports Fiscal Third Quarter 2021 Highlights
31 Jan 2022 //
GLOBENEWSWIRE
Algernon Discloses Novel Salt Patent Strategy as Part of Psychedelic Drug DMT IP
24 Jan 2022 //
GLOBENEWSWIRE
Algernon Files for Trial and Ethics Approval for Phase 1 DMT Human Stroke Study
19 Jan 2022 //
GLOBENEWSWIRE
Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs
24 Nov 2021 //
BIOSPACE
Biomind Labs Completes Development of Thermosensitive Nasal Gel
18 Nov 2021 //
BUSINESSWIRE
Beckley Psytech Announces First Cohort Dosed in Phase 1 Clinical Trial
25 Oct 2021 //
BUSINESSWIRE
Algernon Confirms DMT Increased Growth of Neurons by 40% in Preclinical Study
07 Sep 2021 //
GLOBENEWSWIRE
Biomind Labs Files Patent Application in the US Patent and Trademark Office
12 Aug 2021 //
BUSINESSWIRE
IntelGenx inks deals to develop oral film psychedelics for psychiatric use
16 Sep 2020 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.